Case Studies

Each national public health institute is different and develops in a unique way. To understand the factors that supported the successful creation and growth of our member NPHIs, IANPHI talked to the leaders of several institutes to understand how their NPHIs had been created – why are NPHIs formed, key ingredients to their successes, and barriers to greater impact. The series of case studies reveal the stories of the NPHIs and provide insights into the process of NPHI development that we hope will be useful to others. 


Examples of Case Studies

ethiopia

Ethiopia Public Health Institute (EPHI)

In 2013, EPHI was created from one primary precursor organization, the Ethiopian Health and Nutrition Research Institute (EHNRI), but is the final result of nearly 90 years of evolving public health institute arrangements in Ethiopia. 


Institut Pasteur du Maroc

Institut Pasteur du Maroc 

In Morocco, NPHI functions are dispersed among three agencies. Professor Mohammed Hassar describes his vision for consolidating into a single institute and the potential benefits and challenges associated with such a consolidation. 
In 2002, a government restructuring provided an opportunity to create an NPHI in South Africa. Professor Barry Schoub describes the critical factors in ensuring the success of a new agency.

Public Health Agency of Canada

Public Health Agency of Canada 

In 2003, outbreaks of severe acute respiratory syndrome (SARS) resulted in a public health crisis in Canada and led to the creation of a new NPHI. Dr. David Butler-Jones provides his perspectives on issues and lessons learned in developing an NPHI.

CDC

U. S. Centers for Disease Control and Prevention 

From its roots as an agency fighting malaria, CDC has become one of the largest and most influential public health institutions in the world. Dr. David Sencer describes the growth of CDC and some of its challenges. 

In Canada, the SARS outbreak illustrated deficiencies in the public health system, which led to calls for formation of an NPHI.